Skip to main content
. 2021 Jun 16;10(13):e018086. doi: 10.1161/JAHA.120.018086

Figure 2. Cumulative event curves for hospitalization among hypertensive individuals with a positive SARS‐CoV‐2 test in the outpatient setting during May to August, 2020 (secondary outpatient cohort) comparing (A) ACE inhibitor vs other; (B) ARB vs other; (C) ACE inhibitor vs ARB.

Figure 2

Plots represent propensity score–matched groups. ACE indicates angiotensin‐converting enzyme; and ARB, angiotensin receptor blocker.